Evidence map›Paper›PMID 39149231›Full record

ArticlebioRxiv : the preprint server for biology2024

Discovery of ICOS-targeted small molecules using affinity selection mass spectrometry screening.

Longfei Zhang, Laura Calvo-Barreiro, Victor de Sousa Batista, Katarzyna Świderek, Moustafa T Gabr

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Longfei ZhangDepartment of Radiology, Molecular Imaging Innovations Institute (MI3), Weill Cornell Medicine, New York, NY 10065, USA.
Laura Calvo-BarreiroDepartment of Radiology, Molecular Imaging Innovations Institute (MI3), Weill Cornell Medicine, New York, NY 10065, USA.
Victor de Sousa BatistaBioComp group, Institute of Advanced Materials (INAM), Universitat Jaume I, Spain.
Katarzyna ŚwiderekBioComp group, Institute of Advanced Materials (INAM), Universitat Jaume I, Spain.
Moustafa T GabrDepartment of Radiology, Molecular Imaging Innovations Institute (MI3), Weill Cornell Medicine, New York, NY 10065, USA.

Funding

Optimization of small molecule immunomodulators as combination therapy for IBDR01DK137299 · NIDDK · WEILL MEDICAL COLL OF CORNELL UNIV · PI Moustafa Gabr · 2024 to 2026
$2.0M
NIDDK NIH HHS R01 DK137299
6 · The paper itself

Abstract

Inducible T cell co-stimulator (ICOS) is a positive immune checkpoint receptor expressed on the surface of activated T cells, which could promote cell function after being stimulated with ICOS ligand (ICOS-L). Although clinical benefits have been reported in the ICOS modulation-based treatment for cancer and autoimmune disease, current modulators are restricted in biologics, whereas ICOS-targeted small molecules are lacking. To fill this gap, we performed an affinity selection mass spectrometry (ASMS) screening for ICOS binding using a library of 15,600 molecules. To the best of our knowledge, this is the first study that utilizes ASMS screening to discover small molecules targeting immune checkpoints. Compound

Indexed as

affinity selection mass spectrometry (ASMS)docking studiesICOSimmune checkpointsMD simulations

Identifiers

PMID39149231
PMCPMC11326138

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.